Saturday, December 06, 2025 | 02:28 AM ISTहिंदी में पढें
Page 2 - Biocon Usfda Approval
Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility
Biocon Biologics, through its partner Mylan, has commercialised three of its co-developed biosimilars in developed markets like the US, Canada, the European Union and Australia.
 "Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility")
Updated On : 27 Nov 2019 | 12:44 PM IST
USFDA approvals can unlock $1 bn biosimilar business for Biocon in the US
We have at least a five-year head start in biosimilars compared with other Indian drugmakers, says Mazumdar-Shaw
Updated On : 20 Mar 2018 | 10:11 AM IST
